In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of ...

Merck is holding strong among billionaire favorites, despite the broader healthcare sector dodging investor affection like a ...

Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.

Merck Animal Health announced it will donate $50,000 to the National Professional Agricultural Student Organization to ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...

President Donald Trump announced a 90-day pause on all tariffs except for those against China, which he said would now rise ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data sho ...